Azacitidine Maintenance Therapy After Allogeneic Bone Marrow Transplantation (Allo BMT)
Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
Primary Objective:
-To determine the dose and schedule combination of 5-Azacitidine, when used as maintenance
treatment after allogeneic transplantation for high-risk AML / MDS.
Secondary Objective:
-To assess the effect of treatment on survival after allogeneic transplantation for high-risk
AML / MDS.